Medroxyprogesterone Acetate Injection, Suspension
Product Images NDC 70518-4324

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 70518-4324). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for medroxyprogesterone acetate 150 mg/mL injectable suspension in a prefilled single-dose 1 mL syringe. The label indicates intramuscular use and instructs shaking vigorously before use. It is repackaged by RemedyRepack Inc. with manufacturing by Amneal Pharma, India.*

FDA Label Image

Figure 1 (Medroxyprogesterone Acetate Injectable Suspension 1)

A forest plot chart depicting odds ratios from multiple studies on medroxyprogesterone acetate (DMPA) use. Each study is listed with its corresponding odds ratio represented by a box and horizontal confidence interval lines, along with numerical values displayed on the right side. The horizontal axis is labeled 'Odds Ratio (ratio > 1 indicates increased risk for DMPA)' ranging from 0.6 to 7.4.*

FDA Label Image

Chemical Structure (Medroxyprogesterone Acetate Injectable Suspension 2)

Chemical structure diagram of medroxyprogesterone acetate, showing carbon rings and functional groups with labeled carbon positions in blue.*

FDA Label Image

1 (Medroxyprogesterone Acetate Injectable Suspension 3)

An illustration showing pregnancy rates per 100 women per year based on different birth control methods. The vertical arrow indicates fewer pregnancies at the top and more pregnancies at the bottom. Various methods are grouped in boxes from top to bottom: Implants, injections, intrauterine devices, sterilization; birth control pills, skin patch, vaginal ring with hormones; condoms and diaphragm; no sex during fertile days, spermicide, withdrawal; and no birth control at the bottom.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.